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EXPLANATORY MEMORANDUM 
1.  INTRODUCTION. 
Parliament  has  given  its  first  reading  to  the proposal  for  the  amendment of 
Council  Directive  92/109/EEC  on  the  manufacture  and  the  placing  on  the 
market of  certain substances used in the illicit manufacture of narcotic drugs and 
psychotropic substances. 
The rapporteur, Mr Pirker,  supported the Commission initiative and proposed 
five ame.ndments (cf. PE 273.79611). The amendments were adopted by absolute 
majority  ~ote,  with  the  exception  of amendment 2,  only  part  of which  was 
approved.· 
2.  0BJECI'IVES OF THE COMMISSION PROPOSAL 
3. 
Article 12  of the  1988  United  Nations  Convention  uguinsl  lllicil  Traffk  in  . 
Narcotic Drugs and Psychotropic Substances (Vienna Convention), to which thr 
Community is  a contracting party, provides for trade  in  22  substances which. 
while  also  having  numerous  licit  uses,  are  frequently  diverted  for  use  in  the 
illicit  manufacture  of  narcotic  drugs  and  psychotropic  substances  to  be 
contro11ed. In accordance with the Convention, the manufacture and placing on 
the Community market of such substances are subject to strict surveillance.  in 
particular  pursuant  to Directive  92/109/EEC,  hereinafter  referred  to  as  the 
"Directive on Drug Precursors". 
The Commission proposed that  the  Directive  on  Drug  Precursors  should  be 
amended to take account of the changeable nature of the illicit manufacture of 
narcotic drugs. 
The  aim  of the  amendment  proposed  by  the  Commission  is • to  oblige  the 
Member States to set up a flexible cooperation arrangement by means of which 
economic  operators  would,  on  a  voluntary  basis,  inform  the  competent 
authorities of suspect transactions  involving substances,  not  cutTently  covered 
by the Directive, but which are nevertheless frequently used in the manufacture 
of synthetic drugs. This cooperative approach has already been tried and tested 
in a number of Member States (D, A, UK, NL). The "Precursors" Committee set 
up  by  Article 10  of this  Directive  will  be  responsible  for  drawing  up  and 
constantly  updating  the  lists  of products  which  are  to  be  subject  to  such 
surveillance.  · 
FIRST READING BY PARLIAMENT 
On  20 November 1998 Parliament gave its  first reading to the proposal for the 
amendment  of Council  Directive  92/109/EEC  on  the  manufacture  and  the 
placing on the  market of certain substances  used  in  the  illicit  manufacture of 
narcotic drugs and psychotropic substances. 
2 Presenting  his  report,  Mr Pirker  supported  the  Commission's  initiative  and 
called for increased cooperation with the countries applying for accession to _the 
EU, in particular through the Phare programme. 
He also proposed five amendments. The amendments were adopted by absolute 
majority  vote,  with  the  exception  of amendment 2,  only  part  of which  was 
approved.  These  changes  do  not  substantially  alter  the  substance  of  the 
Directive. 
4.  CONCLUSION 
The first two amendments, of a semantic or linguistic nature, can be accepted by 
the Commission. The third amendment, intended to achieve greater security. can 
also be accepted. 
The  fourth  amendment,  which  would  oblige  the  Commission  to  submit  an 
annual report to Parliament on the results of monitoring measures for scheduled 
and  non-scheduled  substances,  cannot  be  accepted,  as  such  a  report  would 
duplicate the annual report which the Commission already draws up  under the 
existing Directive for submission to the International Narcotics Control Board. 
-Moreover,  the  information  currently  provided by  the  Member  States  is  very 
patchy and does not permit an evaluation of the effectiveness of the system set 
up by the Directive. A fortiori, an evaluation of an arrangement which is not yet 
operational would be all the more uncertain. 
The Commission has also rejected patt of the fifth amendment. The Commission 
has not accepted the proposal to specify that the lists of products to be subject to 
surveillance drawn up by the Committee on Drug Precursors are not accessible 
to  the  public,  as  it  goes  without  saying  that  the  work of the  Committee  is 
confidential. However, the second part of the amendment has been accepted, as 
this point is perfectly acceptable. 
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Amended proposal for a 
EUROPEAN PARLIAMENT AND COUNCIL DIRECTIVE 
amending Council Directive 92/109/EEC on the manufacture and the placing on 
the market of certain substances used in the illicit manufacture of narcotic drugs 
and psychotropic substances 
(Text with EEA relevance) 
THE EUROPEAN  PARLIAMENT  AND  THE COUNCIL  OF THE  EUROPEAN 
UNION, 
'{ 
Having regard to the Treaty establishing the  European Community and in  particular 
Article 1  OOA thereof, 
Having regard to the proposal from the Commission 
1
, 
Having regard to .the opinion of  the Economic and Social Committee
2
, 
Acting in accordance with the procedure laid down in Article 189B of  the Treaty, 
Whereas  Council  Directive  92/109/EEC
3  imposes  stringent  controls  on  the 
manufacture and the placing on the market of 22 substances which  may. be diverted 
into the illicit maitUfacture of narcotic drugs or psychotropic substances; 
Original proposal 
Whereas  Annex I  of  the  Directive 
contains  a  list  of  22  substances 
commonly  used  in  .  the  illicit 
manufacture of drugs, 
Whereas  a  significant  number  of other 
substances,' many of them traded  legally 
in  large  quantities,  have  been  identified 
as  precursors to the  illicit  manufacture of 
synthetic drugs; 
2 
JO 
JO 
OJ L 370, 19.12:1992, p. 76. 
Amended Proposal 
Whereas  Annex I  of  the  Directive 
contains  a  list  of  22  substances 
commonly  used  in  the  illicit 
manufacture  of  narcotic  drugs  and 
psychotropic substances; 
Whereas a significant number of other 
substances,  many  of  the111  traded 
legally  in  large  quantities.  have  hcen 
identified  as  precursors  to  the  illicit 
manufacture of synthetic drugs~ Whereas to subject these substances to 
the same strict controls as those listed 
in  Annex I  would  present  an 
unnecessary obstacle to trade involving 
licences to operate and documentation 
of transactions; whereas it is  therefore 
necessary to establish  a  more  flexible 
mechanism  at  Community  level 
whereby  the  competent  authorities  in 
the  Member States can be  notified of 
susptctous  transactions  in  these 
substances and take appropriate action, 
HAVE ADOPTED THIS DIRECTIVE 
Article 1 
Whereas to subject these substances to 
the same strict controls as those listed 
in  Annex I  would  present  an 
unnecessary  obstacle  to  trade 
involving  licences  to  operate  and 
documentation  of  transactions; 
whereas  it  is  therefore  necessary  to 
establish a more flexible mechanism at 
Community  level  whereby  the 
competent  authorities  in  the  Member 
States  can  be  notified  of suspicious 
transactions  in  these  substances  and 
take appropriate action, 
Article 1 
Council  Directive  92/109/EEC  on  the  Council  Directive  92/109/EEC  on  the 
manufacture  and  the  placing  on  the  manufacture  and  the  placing  on  the 
market of certain substances used in  the  market of certain substances used in  the 
illicit  manufacture of narcotic drugs and  illicit  manufacture of narcotic  drugs and 
psychotropic  substances  is  hereby  psychotropic  substances  is  hereby 
amended as follows:  amended as follows: 
l. The title  of Article 5  is  amended  to  1.  The  title  of Article 5  is  amended  to 
read as follows:  read as follows: 
"Cooperation 
substances" 
regarding  scheduled  "Cooperation  regarding  scheduled 
2.  After Article 5,  a  new Article Sa  is 
inserted as follows: 
"Article Sa 
Cooperation regarding 'non-scheduled 
substances 
Member  States  shall  take  appropriate 
measures to establish close <;ooperation 
bet ween the competent authorities and 
operators,  so  that  operators,  on  a 
voluntary  basis,  notify  the  competent 
authorities  immediately  of  any 
circumstances, such  as  unusual  orders 
and  transactions  involving  any  non-
scheduled  substances,  which  suggest 
t11at  such  substances  may  be  diverted 
.5 
substances" 
2.  After Article 5,  a  new  Article 5a is 
inserted as follows: 
"Article Sa 
Cooperation regarding non-scheduled 
substances 
Member States  shall  take  appropriate 
measures  to  establish  close 
cooperation  between.  the  competent 
authorities  and  operators,  so  that 
operators, on a voluntary hasrs, inform 
the competent authorities  immediately 
of any circumstances, such as  unusual 
orders  and  transactions  involving  any 
non-scheduled  substances,  which 
suggest  that  such  substances  may  be 
' ' . 
for  the  illicit  manufacture  of narcotic 
drugs or psychotropic substances." 
3. In Article 6, the following paragraph 
is added: 
"2.  With  a  view  to  pursuing  tije 
objectives  of  this  Directive  as 
described in Article 1(1), the competent 
authorities of each Member State may 
prohibit  transactions  of non-scheduled . 
substances  if  there  are  reasonable 
grounds  for  suspecting  that  these 
substances  are  intended  for  the  illicit 
manufacture  of  narcotic  drugs  or 
psychotropic substances." 
4.  In  Article 10,  paragraph  1,  the 
following subparagraph is added: 
"In  particular,  with  a  view  to 
facilitating  cooperation  under 
Article 5a and to  ensuring  a  coherent 
approach  throughout  the  Community, 
the  committee  shall  establish  and 
regularly update a list of non-scheduled 
substances  which,  according  to  the 
experience of competent authorities  in 
the  Member  States  or  available  at 
international  level,  are  known  to  be 
used frequently in illicit manufacture. It 
shall  also  establish  for  which  non-
scheduled  substances  in  this  list 
Article 5a  shall  apply  in  all  Member 
States.  More  generally,  information 
shall  be  exchanged  within  the 
committee on  the  current  situation  as-
regards  the use of new  substances or 
new  diversion  methods,  in  order  to 
facilitate any adaptation of the relevant 
Community provisions that may appear 
necessary." 
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diverted for the illicit  manufacture of 
narcotic  drugs  or  psychotropic 
substances." 
3.  In  Article 6,  the  following 
paragraph is added: 
"2.  With  a  view  _to  pursuing  the 
objectives  of  this  Directive  as 
described  in  Article 1(1),  the 
competent authorities of each Member 
State may prohibit transactions ofnon-
schcduled substances if there is  reason 
to  assume  that  these  substances  arc 
intended for the  illicit  manufacture of 
narcotic  drugs  or  psychotropic 
substances." 
4.  In  Article 10,  paragraph  1.  the 
following subparagraph is added: 
"In  particular,  with  a  view  to 
facilitating  cooperation  under 
Article 5a and to  ensuring a  coherent 
approach throughout  the  Community, 
the  committee  shall  establish  and 
regularly  update  a  list  of  non-
scheduled substances which, according 
to  the  experience  of  competent 
authorities  in  th€  Member  States  or 
available  at  international  level,  are 
known to be  used frequently  in  illicit 
manufacture. It shaH  also establish for 
which  non-scheduled  substances·  in 
this  list  Article 5a shall  apply  in  all 
Member  States.  More  generally, 
information shall be exchanged within 
the committee on the current situation 
as regards the use of new substances or  • 
new  diversion  methods,  in  order  to 
facilitate any adaptation of the relevant 
Community  and  national  provisions 
that may appear necessary." Article 2 
1.  Member States shall bring into force the laws, regulations and administrative 
provisions  necressary  to  comply  with  this  Directive  before  30 June 2000. 
They shall forthwith inform the Commission thereof. They shall apply these 
provisions from 1 July 2000. 
2.  When Member States adopt these measures, they shall contain a reference to 
this Directive or shall be accompanied by such a reference on the occasion of 
their official publication. The methods of making such a  reference shall be 
determined by the Member States. 
Article 3 
This Directive is addressed to the Member States. 
Done at Brussels, 
For the European Parliament 
The President 
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For the Council 
The President •, 
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FINANCIAL STATEMENT 
1.  TITLE OF OPERATION 
Amended  proposal  for  a  DIRECTIVE  OF  THE  EUROPEAN 
PARLIAMENT  AND  OF  THE  COUNCIL  amending  Council  Directive 
92/1 09/EEC on the  manufacture  and the  placing on the  market of certain 
substances used in the illicit manufacture of narcotic drugs and psychotropic 
substances. 
2.  BUDGET HEADING INVOLVED 
N/A. 
.3.  LEGAL BASIS 
Article 100 A of the EU Treaty. 
· 4.  DESCRIPTION OF OPERATION 
4.1  General objective 
The objective of  the amendment proposed by the Commission is to oblige the 
Member States to set up  a flexible  cooperation arrangement  by  means of 
which economic operators would, on a voluntary basis, inform the competent 
authorities of suspect transactions involving substances not currently covered 
by Directive 921109/EEC but which are nevertheless frequently used in  the 
manufacture of synthetic drugs_. 
4.2  Period covered and--arrangements for renewal or extension 
Indefinite. 
5.  CLASSIFICATION OF EXPENDITURE OR REVENUE 
5.1  Compulsory/Non-compulsory expenditure 
Nil. 
5.2  Differentiated/Non-differentiated appropriations 
Nil. 
5.3  Type of revenue involved 
Nil. 
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6.  TYPE OF EXPENDITURE OR REVENUE 
- Directive with no financial implications. 
7.  FINANCIAL IMPACT 
7.1  Method of calculating total cost of  operation (defmition ofunitcosts) 
7.2  Itemised breakdown of  cost 
Commitment appropriations in million Euro (current price~) 
) 
Breakdown  Budget  n+l  n+2  n+3  n+4  n+S  Total 
yearn  and 
subs. 
years 
Total 
7.3  Operating ~xpenditure on studies, experts, etc. included in part 8 of the 
budget 
Commitment appropriations in million Euro (current prices) 
Budget  n+l  n+2  n+3  n+4  n+5  Total 
yearn  and 
subs. 
years 
- Studies 
- Expert meetings 
- Conference and 
symposia 
- Information and 
publications 
Total 
9 7.4  Indicative  schedule  of  commitment  appropriations/payment 
appropriations 
Commitment appropriations in million Euro 
Budget  n+l  n+2  n+3  n+4  n+5  Total 
yearn  and 
subs. 
-
years 
-
Commitment approps 
Payment approps 
Yearn 
n+l 
n+2 
n+3 
n+4 
n+5 
and subs. years 
Total 
8.  FRAUD PREVENTION MEASURES 
- Nil. 
9.  ELEMENTS OF COST  -EFFECTIVENESS ANALYSIS 
9.1  Specific and quantified objectives, target population 
- Specific objectives: nil. 
- Target  population:  any  natural  or  legal  person  involved  in  the 
manufacture,  processing,  trade or distribution of classified substances  in 
the  Community  or  carrying  out  other related  activities,  such  as  the 
brokerage and storage of  classified substances. 
9.2  Grounds for the operation 
- Choice of ways and means 
* voluntary  cooperation  between  operators  and  authorities  in  the 
Member States 
lO 9.3  Monitoring and evaluation of the operation 
- Performance indicators selected 
* "Precursors" Committee set up by Article 10 of this Directive. 
10.  ADMINIS.TRATIVE EXPENDITURE (PART A OF SECTION III OF 
THE GENERAL BUDGET) 
This section of the financial statement must be sent to DGs IX and XIX; DG IX will 
then forward it to DG XIX with its opinion. 
The actual mobilisation of the necessary administrative resources will result from the 
annual decision by the Commission on the allocation of resources, having regard to 
among other things the additional staff and funds granted by the budgetary authority. 
10.1  Impact on the number of posts 
No effect on the number of  posts. 
Types of posts  Staff  to be assigned to  of which  duration 
the management of the 
operation 
permanent  temporary  by using existing  by using 
posts  posts  resources within  additional 
the DG or service  resources 
in question 
Officials or  A 
temporary  B 
staff  c 
Other resources 
" 
Total 
Indicate the rate at which additional resources would have. to be made available. 
ll 10.2  Global fmancial impact of additional human re~urces 
No impact. 
(Euro) 
Amounts  Method of  calculation 
Officials 
Temporary staff 
Other resources 
(indicate budget 
heading) 
Total 
The amounts represent the total cost of additional posts for the total duration of the 
operation if this is  fixe~, and for 12 months if the duration is not specified. 
10.3  Increase in other operating expenditure resulting from the operation 
No effect. 
(Euro) 
Budget heading  Amounts  Method of calculation 
(No
0and title) 
-
Total 
~The amounts correspond to the total expenditure on  the  operation  if.  it  is  of fixed 
duration or the expenditure for 12 months if the duration is not specified. 
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